Get started
Author

Chanchal Goswami

Observed names: Goswami Chanchal, Goswami, Chanchal
Institution: AMRI Hospitals
OpenAlex ID: A5110043922
Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
2013 · Charles S Fuchs, Jiri Tomasek, et al. · The Lancet · 2,191
Neratinib Plus Paclitaxel vs Trastuzumab Plus Paclitaxel in Previously Untreated Metastatic ERBB2-Positive Breast Cancer: The NEfERT-T Randomized Clinical Trial
2020 · Xu, Feng, Awada, Ahmad, et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill) · 482
Neratinib Plus Paclitaxel vs Trastuzumab Plus Paclitaxel in Previously Untreated Metastatic ERBB2-Positive Breast Cancer
2016 · Ahmad Awada, Ramon Colomer, et al. · JAMA Oncology · 305
PDF
Intravenous aflibercept for treatment of recurrent symptomatic malignant ascites in patients with advanced ovarian cancer: a phase 2, randomised, double-blind, placebo-controlled study
2011 · Walter H Gotlieb, Frederic Amant, et al. · The Lancet Oncology · 151
Final Results of RIGHT Choice: Ribociclib Plus Endocrine Therapy Versus Combination Chemotherapy in Premenopausal Women With Clinically Aggressive Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer
2024 · Yen-Shen Lu, Eznal Izwadi Bin Mohd Mahidin, et al. · Journal of Clinical Oncology · 91
Clinical and epidemiological study of EGFR mutations and EML4-ALK fusion genes among Indian patients with adenocarcinoma of the lung
2015 · Sanjay Gupta, Dinesh Doval, et al. · OncoTargets and Therapy · 61
PDF
Prevalence of BRCA1 and BRCA2 Mutations Among Patients With Ovarian, Primary Peritoneal, and Fallopian Tube Cancer in India: A Multicenter Cross-Sectional Study
2021 · Sudeep Gupta, Senthil Rajappa, et al. · JCO Global Oncology · 42
PDF
REGARD: A phase III, randomized, double-blinded trial of ramucirumab and best supportive care (BSC) versus placebo and BSC in the treatment of metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma following disease progression on first-line platinum- and/or fluoropyrimidine-containing combination therapy.
2013 · Charles S. Fuchs, Jiri Tomasek, et al. · Journal of Clinical Oncology · 42
Histopathological pattern of lymphomas and clinical presentation and outcomes of diffuse large B cell lymphoma: A multicenter registry based study from India
2013 · Ramesh B.V. Nimmagadda, Raghunadharao Digumarti, et al. · Indian Journal of Medical and Paediatric Oncology · 38
PDF
Post-irradiation angiosarcoma of bone
2007 · Srabani Mittal, Chanchal Goswami, et al. · Journal of Cancer Research and Therapeutics · 32
Age does not influence efficacy of ramucirumab in advanced gastric cancer: Subgroup analyses of REGARD and RAINBOW
2017 · Kei Muro, Jae Yong Cho, et al. · Journal of Gastroenterology and Hepatology · 28
PDF
Expert Consensus on Effective Management of Chemotherapy-Induced Nausea and Vomiting: An Indian Perspective
2020 · Ashok K. Vaid, Sudeep Gupta, et al. · Frontiers in Oncology · 26
PDF
Nimotuzumab plus chemotherapy versus chemotherapy alone in advanced non-small-cell lung cancer: a multicenter, randomized, open-label Phase II study
2014 · Govind K Babu, Ashok K Vaid, et al. · OncoTargets and Therapy · 25
PDF
REGARD: A phase 3, randomized, double-blind trial of ramucirumab (RAM) and best supportive care (BSC) versus placebo (PL) and BSC in the treatment of metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma following disease progression (PD) on first-line platinum- and/or fluoropyrimidine-containing combination therapy: Age subgroup analysis.
2014 · Charles S. Fuchs, Jiri Tomasek, et al. · Journal of Clinical Oncology · 21
A multicenter phase II randomized study of Cremophor‐free polymeric nanoparticle formulation of paclitaxel in women with locally advanced and/or metastatic breast cancer after failure of anthracycline
2012 · Anantbhushan A Ranade, Poonamalle P Bapsy, et al. · Asia-Pacific Journal of Clinical Oncology · 21
Primary Ewing′s sarcoma of the squamous part of temporal bone in a young girl treated with adjuvant volumetric arc therapy
2015 · Moujhuri Nandi, Jibak Bhattacharya, et al. · Journal of Cancer Research and Therapeutics · 7
Efficacy and CNS progression analysis from the randomized phase 2 trial of neratinib + paclitaxel vs trastuzumab + paclitaxel as first-line treatment for HER2+ metastatic breast cancer (NEfERTT).
2015 · Ahmad Awada, Ramon Colomer, et al. · Journal of Clinical Oncology · 7
A Randomized, Double-Blind, Phase III Study in India for Comparing Efficacy, Safety, and PK of ZRC-3277 (Pertuzumab Biosimilar) With Perjeta® in Patients With HER2-Positive Metastatic Breast Cancer
2024 · Rushabh Kothari, Maulik Doshi, et al. · Clinical Breast Cancer · 6
Efficacy and safety of ramucirumab (RAM) for metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma across age subgroups in two global phase 3 trials.
2017 · Kei Muro, Jae Yong Cho, et al. · Journal of Clinical Oncology · 4
Regard Phase 3, Randomized Trial of Ramucirumab in Patients with Metastatic Gastric or Gej Adenocarcinoma Following Progression on First-Line Chemotherapy
2013 · Josep Tabernero, Jiri Tomasek, et al. · Annals of Oncology · 3
Nimotuzumab plus chemotherapy versus chemotherapy alone in advanced non-small cell lung cancer: A phase II, open-label, multicenter, randomized study.
2013 · Kumar Prabhash, Kanaka Govind Babu, et al. · Journal of Clinical Oncology · 3
Abstract PS13-25: Management of abemaciclib associated diarrhea in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: Analysis of the MONARCH plus study
2021 · Zefei Jiang, Xichun Hu, et al. · Cancer Research · 1
Indian Expert Opinion on Cancer Care during COVID-19 Pandemic
2021 · Ashok K. Vaid, Hemant Malhotra, et al. · South Asian Journal of Cancer · 1
PDF
A non-interventional, multicenter study to assess prevalence of BRCA1 and BRCA2 mutation among ovarian, primary peritoneal, and fallopian tube cancer patients in India.
2019 · Rohit Kodagali, Sudeep Gupta, et al. · Journal of Clinical Oncology · 1
Role of molecular diagnostics in determination of tissue of origin in Cancer of Unknown Primary (CUP)
2019 · Amit Verma, Chanchal Goswami, et al. · International Journal of Molecular and Immuno Oncology · 1
Works count: 34
Citation count: 3,591
H-index: 15
I10-index: 15
Year
Topic
Type